• レポートコード:QFJ1-4373 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、95ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、注射式鎮痛薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(非ステロイド性抗炎症薬(NSAID)、中枢作用性鎮痛薬)、用途別市場規模(病院、クリニック、リカバリーセンター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。 ・市場概要 ・注射式鎮痛薬の市場動向 ・企業の競争状況、市場シェア ・注射式鎮痛薬の種類別市場規模と予測2016-2027(非ステロイド性抗炎症薬(NSAID)、中枢作用性鎮痛薬) ・注射式鎮痛薬の用途別市場規模と予測2016-2027(病院、クリニック、リカバリーセンター) ・注射式鎮痛薬の北米市場規模2016-2027(アメリカ、カナダ) ・注射式鎮痛薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等) ・注射式鎮痛薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・注射式鎮痛薬の中南米市場規模2016-2027(メキシコ、ブラジル) ・注射式鎮痛薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(GlaxoSmithKline、Merck、Pfizer、Novartis、Sanofi、Bayer、Johson & Johson、Boehringer Ingelheim、Sun Pharmaceutical) ・結論 |
Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief.
Market Analysis and Insights: Global Injectable Pain Medication Market
The global Injectable Pain Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Pain Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Pain Medication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Pain Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Pain Medication market.
Global Injectable Pain Medication Scope and Market Size
Injectable Pain Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Pain Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Central Analgesics
Segment by Application
Hospital
Clinics
Recovery Center
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
Merck
Pfizer
Novartis
Sanofi
Bayer
Johson & Johson
Boehringer Ingelheim
Sun Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Pain Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.3 Central Analgesics
1.3 Market by Application
1.3.1 Global Injectable Pain Medication Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Injectable Pain Medication Market Perspective (2016-2027)
2.2 Injectable Pain Medication Growth Trends by Regions
2.2.1 Injectable Pain Medication Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Injectable Pain Medication Historic Market Share by Regions (2016-2021)
2.2.3 Injectable Pain Medication Forecasted Market Size by Regions (2022-2027)
2.3 Injectable Pain Medication Industry Dynamic
2.3.1 Injectable Pain Medication Market Trends
2.3.2 Injectable Pain Medication Market Drivers
2.3.3 Injectable Pain Medication Market Challenges
2.3.4 Injectable Pain Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Pain Medication Players by Revenue
3.1.1 Global Top Injectable Pain Medication Players by Revenue (2016-2021)
3.1.2 Global Injectable Pain Medication Revenue Market Share by Players (2016-2021)
3.2 Global Injectable Pain Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Injectable Pain Medication Revenue
3.4 Global Injectable Pain Medication Market Concentration Ratio
3.4.1 Global Injectable Pain Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Pain Medication Revenue in 2020
3.5 Injectable Pain Medication Key Players Head office and Area Served
3.6 Key Players Injectable Pain Medication Product Solution and Service
3.7 Date of Enter into Injectable Pain Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Pain Medication Breakdown Data by Type
4.1 Global Injectable Pain Medication Historic Market Size by Type (2016-2021)
4.2 Global Injectable Pain Medication Forecasted Market Size by Type (2022-2027)
5 Injectable Pain Medication Breakdown Data by Application
5.1 Global Injectable Pain Medication Historic Market Size by Application (2016-2021)
5.2 Global Injectable Pain Medication Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Injectable Pain Medication Market Size (2016-2027)
6.2 North America Injectable Pain Medication Market Size by Type
6.2.1 North America Injectable Pain Medication Market Size by Type (2016-2021)
6.2.2 North America Injectable Pain Medication Market Size by Type (2022-2027)
6.2.3 North America Injectable Pain Medication Market Size by Type (2016-2027)
6.3 North America Injectable Pain Medication Market Size by Application
6.3.1 North America Injectable Pain Medication Market Size by Application (2016-2021)
6.3.2 North America Injectable Pain Medication Market Size by Application (2022-2027)
6.3.3 North America Injectable Pain Medication Market Size by Application (2016-2027)
6.4 North America Injectable Pain Medication Market Size by Country
6.4.1 North America Injectable Pain Medication Market Size by Country (2016-2021)
6.4.2 North America Injectable Pain Medication Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Injectable Pain Medication Market Size (2016-2027)
7.2 Europe Injectable Pain Medication Market Size by Type
7.2.1 Europe Injectable Pain Medication Market Size by Type (2016-2021)
7.2.2 Europe Injectable Pain Medication Market Size by Type (2022-2027)
7.2.3 Europe Injectable Pain Medication Market Size by Type (2016-2027)
7.3 Europe Injectable Pain Medication Market Size by Application
7.3.1 Europe Injectable Pain Medication Market Size by Application (2016-2021)
7.3.2 Europe Injectable Pain Medication Market Size by Application (2022-2027)
7.3.3 Europe Injectable Pain Medication Market Size by Application (2016-2027)
7.4 Europe Injectable Pain Medication Market Size by Country
7.4.1 Europe Injectable Pain Medication Market Size by Country (2016-2021)
7.4.2 Europe Injectable Pain Medication Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Injectable Pain Medication Market Size (2016-2027)
8.2 Asia-Pacific Injectable Pain Medication Market Size by Type
8.2.1 Asia-Pacific Injectable Pain Medication Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Injectable Pain Medication Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Injectable Pain Medication Market Size by Type (2016-2027)
8.3 Asia-Pacific Injectable Pain Medication Market Size by Application
8.3.1 Asia-Pacific Injectable Pain Medication Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Injectable Pain Medication Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Injectable Pain Medication Market Size by Application (2016-2027)
8.4 Asia-Pacific Injectable Pain Medication Market Size by Region
8.4.1 Asia-Pacific Injectable Pain Medication Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Injectable Pain Medication Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Injectable Pain Medication Market Size (2016-2027)
9.2 Latin America Injectable Pain Medication Market Size by Type
9.2.1 Latin America Injectable Pain Medication Market Size by Type (2016-2021)
9.2.2 Latin America Injectable Pain Medication Market Size by Type (2022-2027)
9.2.3 Latin America Injectable Pain Medication Market Size by Type (2016-2027)
9.3 Latin America Injectable Pain Medication Market Size by Application
9.3.1 Latin America Injectable Pain Medication Market Size by Application (2016-2021)
9.3.2 Latin America Injectable Pain Medication Market Size by Application (2022-2027)
9.3.3 Latin America Injectable Pain Medication Market Size by Application (2016-2027)
9.4 Latin America Injectable Pain Medication Market Size by Country
9.4.1 Latin America Injectable Pain Medication Market Size by Country (2016-2021)
9.4.2 Latin America Injectable Pain Medication Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Pain Medication Market Size (2016-2027)
10.2 Middle East & Africa Injectable Pain Medication Market Size by Type
10.2.1 Middle East & Africa Injectable Pain Medication Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Injectable Pain Medication Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Injectable Pain Medication Market Size by Type (2016-2027)
10.3 Middle East & Africa Injectable Pain Medication Market Size by Application
10.3.1 Middle East & Africa Injectable Pain Medication Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Injectable Pain Medication Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Injectable Pain Medication Market Size by Application (2016-2027)
10.4 Middle East & Africa Injectable Pain Medication Market Size by Country
10.4.1 Middle East & Africa Injectable Pain Medication Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Injectable Pain Medication Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Injectable Pain Medication Introduction
11.1.4 GlaxoSmithKline Revenue in Injectable Pain Medication Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Injectable Pain Medication Introduction
11.2.4 Merck Revenue in Injectable Pain Medication Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Injectable Pain Medication Introduction
11.3.4 Pfizer Revenue in Injectable Pain Medication Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Injectable Pain Medication Introduction
11.4.4 Novartis Revenue in Injectable Pain Medication Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Injectable Pain Medication Introduction
11.5.4 Sanofi Revenue in Injectable Pain Medication Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Injectable Pain Medication Introduction
11.6.4 Bayer Revenue in Injectable Pain Medication Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Johson & Johson
11.7.1 Johson & Johson Company Details
11.7.2 Johson & Johson Business Overview
11.7.3 Johson & Johson Injectable Pain Medication Introduction
11.7.4 Johson & Johson Revenue in Injectable Pain Medication Business (2016-2021)
11.7.5 Johson & Johson Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Injectable Pain Medication Introduction
11.8.4 Boehringer Ingelheim Revenue in Injectable Pain Medication Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Details
11.9.2 Sun Pharmaceutical Business Overview
11.9.3 Sun Pharmaceutical Injectable Pain Medication Introduction
11.9.4 Sun Pharmaceutical Revenue in Injectable Pain Medication Business (2016-2021)
11.9.5 Sun Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Injectable Pain Medication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Table 3. Key Players of Central Analgesics
Table 4. Global Injectable Pain Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Injectable Pain Medication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Injectable Pain Medication Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Injectable Pain Medication Market Share by Regions (2016-2021)
Table 8. Global Injectable Pain Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Injectable Pain Medication Market Share by Regions (2022-2027)
Table 10. Injectable Pain Medication Market Trends
Table 11. Injectable Pain Medication Market Drivers
Table 12. Injectable Pain Medication Market Challenges
Table 13. Injectable Pain Medication Market Restraints
Table 14. Global Injectable Pain Medication Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Injectable Pain Medication Market Share by Players (2016-2021)
Table 16. Global Top Injectable Pain Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Pain Medication as of 2020)
Table 17. Ranking of Global Top Injectable Pain Medication Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Injectable Pain Medication Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Injectable Pain Medication Product Solution and Service
Table 21. Date of Enter into Injectable Pain Medication Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Injectable Pain Medication Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Injectable Pain Medication Revenue Market Share by Type (2016-2021)
Table 25. Global Injectable Pain Medication Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Injectable Pain Medication Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Injectable Pain Medication Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Injectable Pain Medication Revenue Market Share by Application (2016-2021)
Table 29. Global Injectable Pain Medication Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Injectable Pain Medication Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Injectable Pain Medication Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Injectable Pain Medication Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Injectable Pain Medication Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Injectable Pain Medication Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Injectable Pain Medication Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Injectable Pain Medication Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Injectable Pain Medication Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Injectable Pain Medication Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Injectable Pain Medication Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Injectable Pain Medication Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Injectable Pain Medication Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Injectable Pain Medication Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Injectable Pain Medication Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Injectable Pain Medication Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Injectable Pain Medication Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Injectable Pain Medication Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Injectable Pain Medication Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Injectable Pain Medication Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Injectable Pain Medication Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Injectable Pain Medication Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Injectable Pain Medication Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Injectable Pain Medication Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Injectable Pain Medication Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Injectable Pain Medication Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Injectable Pain Medication Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Injectable Pain Medication Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Injectable Pain Medication Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Injectable Pain Medication Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Injectable Pain Medication Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Injectable Pain Medication Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Injectable Pain Medication Product
Table 64. GlaxoSmithKline Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Injectable Pain Medication Product
Table 69. Merck Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Injectable Pain Medication Product
Table 74. Pfizer Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Injectable Pain Medication Product
Table 79. Novartis Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Injectable Pain Medication Product
Table 84. Sanofi Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Injectable Pain Medication Product
Table 89. Bayer Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Johson & Johson Company Details
Table 92. Johson & Johson Business Overview
Table 93. Johson & Johson Injectable Pain Medication Product
Table 94. Johson & Johson Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 95. Johson & Johson Recent Development
Table 96. Boehringer Ingelheim Company Details
Table 97. Boehringer Ingelheim Business Overview
Table 98. Boehringer Ingelheim Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 99. Boehringer Ingelheim Recent Development
Table 100. Sun Pharmaceutical Company Details
Table 101. Sun Pharmaceutical Business Overview
Table 102. Sun Pharmaceutical Injectable Pain Medication Product
Table 103. Sun Pharmaceutical Revenue in Injectable Pain Medication Business (2016-2021) & (US$ Million)
Table 104. Sun Pharmaceutical Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Pain Medication Market Share by Type: 2020 VS 2027
Figure 2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Features
Figure 3. Central Analgesics Features
Figure 4. Global Injectable Pain Medication Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Recovery Center Case Studies
Figure 8. Injectable Pain Medication Report Years Considered
Figure 9. Global Injectable Pain Medication Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Injectable Pain Medication Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Injectable Pain Medication Market Share by Regions: 2020 VS 2027
Figure 12. Global Injectable Pain Medication Market Share by Regions (2022-2027)
Figure 13. Global Injectable Pain Medication Market Share by Players in 2020
Figure 14. Global Top Injectable Pain Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Pain Medication as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Injectable Pain Medication Revenue in 2020
Figure 16. Global Injectable Pain Medication Revenue Market Share by Type (2016-2021)
Figure 17. Global Injectable Pain Medication Revenue Market Share by Type (2022-2027)
Figure 18. North America Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Injectable Pain Medication Market Share by Type (2016-2027)
Figure 20. North America Injectable Pain Medication Market Share by Application (2016-2027)
Figure 21. North America Injectable Pain Medication Market Share by Country (2016-2027)
Figure 22. United States Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Injectable Pain Medication Market Share by Type (2016-2027)
Figure 26. Europe Injectable Pain Medication Market Share by Application (2016-2027)
Figure 27. Europe Injectable Pain Medication Market Share by Country (2016-2027)
Figure 28. Germany Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Injectable Pain Medication Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Injectable Pain Medication Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Injectable Pain Medication Market Share by Region (2016-2027)
Figure 38. China Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Injectable Pain Medication Market Share by Type (2016-2027)
Figure 46. Latin America Injectable Pain Medication Market Share by Application (2016-2027)
Figure 47. Latin America Injectable Pain Medication Market Share by Country (2016-2027)
Figure 48. Mexico Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Injectable Pain Medication Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Injectable Pain Medication Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Injectable Pain Medication Market Share by Country (2016-2027)
Figure 54. Turkey Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Injectable Pain Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 63. Johson & Johson Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 65. Sun Pharmaceutical Revenue Growth Rate in Injectable Pain Medication Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed